PMID- 35389097 OWN - NLM STAT- MEDLINE DCOM- 20220627 LR - 20220627 IS - 1432-2307 (Electronic) IS - 0945-6317 (Linking) VI - 481 IP - 1 DP - 2022 Jul TI - Subtyping of hepatocellular adenoma: a machine learning-based approach. PG - 49-61 LID - 10.1007/s00428-022-03311-w [doi] AB - Subtyping of hepatocellular adenoma (HCA) is an important task in practice as different subtypes may have different clinical outcomes and management algorithms. Definitive subtyping is currently dependent on immunohistochemical and molecular testing. The association between some morphologic/clinical features and HCA subtypes has been reported; however, the predictive performance of these features has been controversial. In this study, we attempted machine learning based methods to select an efficient and parsimonious set of morphologic/clinical features for differentiating a HCA subtype from the others, and then assessed the performance of the selected features in identifying the correct subtypes. We first examined 50 liver HCA resection specimens collected at the University of Washington and Kobe University/Kings College London, including HNF1alpha-mutated HCA (H-HCA) (n = 16), inflammatory HCA (I-HCA) (n = 20), beta-catenin activated HCA (beta-HCA) (n = 8), and unclassified HCA (U-HCA) (n = 6). Twenty-six morphologic/clinical features were assessed. We used LASSO (least absolute shrinkage and selection operator) to select key features that could differentiate a subtype from the others. We further performed SVM (support vector machine) analysis to assess the performance (sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and accuracy) of the selected features in HCA subtyping in an independent cohort of liver resection samples (n = 20) collected at the University of Wisconsin-Madison. With some overlap, different combinations of morphologic/clinical features were selected for each subtype. Based on SVM analysis, the selected features classified HCA into correct subtypes with an overall accuracy of at least 80%. Our findings are useful for initial diagnosis and subtyping of HCA, especially in clinical settings without access to immunohistochemical and molecular assays. CI - (c) 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. FAU - Liu, Yongjun AU - Liu Y AD - Department of Pathology and Laboratory Medicine, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. FAU - Liu, Yao-Zhong AU - Liu YZ AD - Department of Biostatistics and Data Science, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA. FAU - Sun, Lifu AU - Sun L AD - Department of Biostatistics and Data Science, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA, USA. FAU - Zen, Yoh AU - Zen Y AD - Department of Diagnostic Pathology, Kobe University Graduate School of Medicine, Kobe, Japan. AD - Institute of Liver Studies, King's College Hospital & King's College London, London, UK. FAU - Inomoto, Chie AU - Inomoto C AD - Department of Pathology, Tokai University, Isehara, Japan. FAU - Yeh, Matthew M AU - Yeh MM AD - Department of Laboratory Medicine and Pathology, University of Washington School of Medicine, 1959 NE Pacific Street, NE140D, Seattle, WA, 98195-6100, USA. myeh@uw.edu. AD - Department of Medicine, University of Washington School of Medicine, Seattle, WA, USA. myeh@uw.edu. LA - eng PT - Journal Article DEP - 20220407 PL - Germany TA - Virchows Arch JT - Virchows Archiv : an international journal of pathology JID - 9423843 SB - IM MH - *Adenoma, Liver Cell/diagnosis MH - *Carcinoma, Hepatocellular MH - Humans MH - *Liver Neoplasms/chemistry/diagnosis MH - Machine Learning OTO - NOTNLM OT - Feature selection OT - Hepatocellular adenoma (HCA) OT - LASSO OT - Machine learning OT - Support vector machine (SVM) EDAT- 2022/04/08 06:00 MHDA- 2022/06/28 06:00 CRDT- 2022/04/07 12:03 PHST- 2021/10/31 00:00 [received] PHST- 2022/03/13 00:00 [accepted] PHST- 2022/03/08 00:00 [revised] PHST- 2022/04/08 06:00 [pubmed] PHST- 2022/06/28 06:00 [medline] PHST- 2022/04/07 12:03 [entrez] AID - 10.1007/s00428-022-03311-w [pii] AID - 10.1007/s00428-022-03311-w [doi] PST - ppublish SO - Virchows Arch. 2022 Jul;481(1):49-61. doi: 10.1007/s00428-022-03311-w. Epub 2022 Apr 7.